Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Bonus BioGroup Ltd.
  6. Summary
    BONS   IL0004850116

BONUS BIOGROUP LTD.

(BONS)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
06/16/2021 06/17/2021 06/20/2021 06/21/2021 06/22/2021 Date
126.3(c) 125(c) 126.9(c) 126.9(c) 123.6 Last
610 254 557 806 894 089 1 036 975 1 890 688 Volume
+1.04% -1.03% +1.52% 0.00% -2.60% Change
More quotes
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -22,2 M -6,82 M -6,82 M
Net Debt 2019 5,77 M 1,77 M 1,77 M
P/E ratio 2019 -16,8x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -22,0 M -6,75 M -6,75 M
Net cash position 2020 10,9 M 3,35 M 3,35 M
P/E ratio 2020 -22,0x
Yield 2020 -
Capitalization 1 357 M 415 M 416 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 32
Free-Float 57,5%
More Financials
Company
Bonus Biogroup Ltd, formerly Oceana Advanced Industries Ltd, is an Israel-based product-focused biotechnology company applying technology for supplying bone regeneration tissues. The Company is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. It is targeting... 
More about the company
All news about BONUS BIOGROUP LTD.
2020BONUS BIOGROUPá : Wize Pharma's Strategic Transaction Partner Bonus BioGroup to ..
AQ
2020BONUS BIOGROUPá : Wize Pharma's Strategic Transaction Partner Bonus Biogroup Ini..
AQ
More news
News in other languages on BONUS BIOGROUP LTD.

- No features available -

More news
Chart BONUS BIOGROUP LTD.
Duration : Period :
Bonus BioGroup Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BONUS BIOGROUP LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
NameTitle
Shai Meretzki President, Chief Executive Officer & Director
Yoni Livne Chief Financial Officer
Yossi Rauch Chairman
Gil Shapira Director
Yehuda Reznik Director
Sector and Competitors
1st jan.Capitalization (M$)
BONUS BIOGROUP LTD.162.19%415
GILEAD SCIENCES, INC.15.60%84 469
MODERNA, INC.99.33%83 614
WUXI APPTEC CO., LTD.24.70%66 143
REGENERON PHARMACEUTICALS10.59%55 327
BIONTECH SE177.34%54 605